26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ALVAC 36 aminoethylcarbazole (AEC)<br />

ALVAC<br />

An experimental AIDS vaccine developed for the first test<br />

of a human vaccine in Africa. The vaccine has undergone<br />

safety testing in the United States and France with no<br />

serious side effects reported and is being used in Uganda,<br />

where AIDS has killed nearly half a million people and left<br />

one million children orphaned.<br />

alveolar basement membrane autoantibodies<br />

(ABM autoantibodies)<br />

Antibodies present in the blood sera and as linear deposits<br />

on the ABMs of patients with rapidly progressive<br />

glomerulonephritis (RPGN) and pulmonary hemorrhage<br />

(Goodpasture’s syndrome). The antibodies are also present<br />

in the blood sera of patients with glomerular basement<br />

membrane (GBM) nephritis. Not all patients with<br />

GBM nephritis have pulmonary involvement. This may<br />

be explained based on different reactivities with ABMs.<br />

Linear immunoglobulin staining of ABMs in ABM<br />

disease limited to the lungs is highly specific. Endothelial<br />

cell injury, such as that induced by infection, is considered<br />

significant in the pathogenesis of Goodpasture’s<br />

hemorrhagic pneumonitis. Pulmonary hemorrhage has<br />

been associated with antineutrophil cytoplasmic antibodies<br />

(ANCAs) that may sometimes be immunoglobulin M<br />

(IgM) isotype-restricted. In the absence of GBM autoantibodies<br />

and ANCA, intra-alveolar hemorrhage may be<br />

associated with cardiolipin antibodies. Early diagnosis of<br />

patients with these types of clinical conditions is critical,<br />

as mortality rates exceed 75%.<br />

Alveolar macrophages.<br />

alveolar macrophage<br />

A macrophage in the lung alveoli that may remove inhaled<br />

particulate matter.<br />

ALZ-50<br />

A monoclonal antibody that serves as an early indicator of<br />

Alzheimer’s disease by reacting with Alzheimer’s brain tissue,<br />

specifically protein A-68.<br />

Am allotypic marker<br />

An allotypic antigenic determinant located on the heavy<br />

chain of the immunoglobulin A (IgA) molecule in<br />

humans. Of the two IgA subclasses, the IgA1 subclass<br />

has no known allotypic determinant. The IgA2 subclass<br />

has two allotypic determinants designated A2m(1) and<br />

A2m(2), based on differences in a-2 heavy chain primary<br />

structures. Allelic genes at the A2m locus encode these<br />

allotypes that are expressed on the a-2 heavy chain constant<br />

regions.<br />

Am<br />

IgA<br />

Illustration of the location of Am marker specificities on the Fc region.<br />

amboceptor (historical)<br />

Paul Ehrlich (circa 1900) considered anti-sheep red blood<br />

cell antibodies known as amboceptors to have one receptor<br />

for sheep erythrocytes and another receptor for complement.<br />

The term gained worldwide acceptance with the<br />

popularity of complement fixation tests for syphilis, such<br />

as the Wassermann reaction. The term is still used by some<br />

when discussing complement fixation.<br />

amebocytes<br />

Mobile phagocytic cells that mediate defense by phagocytosis<br />

in addition to digestive and excretion functions in<br />

primitive organisms lacking circulatory systems.<br />

amino acyl tRNA synthetases<br />

Myositis-specific autoantibodies that include antibodies<br />

against histidyl tRNA synthetase (HRS), first known as<br />

Jo-1. They are found in 20% of patients with polymyositis<br />

and dermatomyositis. Autoantibodies to analyl (PL-12),<br />

threonyl (PL-7), glycyl (EJ), and isoleucyl (OJ) tRNA<br />

synthetases have also been reported. These aminoacyl<br />

synthetases bind their corresponding amino acids to the<br />

tails of their respective tRNAs. Essentially all Jo-1-positive<br />

sera possess antibodies that react with the amino terminal<br />

(amino acids 1–44) of the protein, but most also have<br />

antibodies against epitopes positioned further toward the<br />

carboxyl end of the sequence. Anti-HRS antibodies are<br />

principally immunoglobulin G 1 (IgG 1) and persist throughout<br />

the course of the disease. Patients with autoantibodies<br />

against tRNA synthetases have several clinical features in<br />

common, including interstitial lung disease and pulmonary<br />

fibrosis (50 to 100%), arthritis (60 to 100%), Raynaud’s<br />

phenomenon (60 to 93%), fever, and “mechanic’s hands.” In<br />

patients with antisynthetase syndrome, anti-Jo-1 antibodies<br />

are most common in polymyositis, whereas autoantibodies<br />

against other aminoacyl–tRNA synthetases are more often<br />

found in dermatomyositis. Antibodies to HRS show a strong<br />

association with HLA-DR3.<br />

aminoethylcarbazole (AEC)<br />

3-amino-9-ethyl carbazole is used in the ABC immunoperoxidase<br />

technique to produce a visible reaction product<br />

detectable by light microscopy when combined with hydrogen<br />

peroxide. AEC is oxidized to produce a reddish-brown

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!